--- type: "News" locale: "en" url: "https://longbridge.com/en/news/270952566.md" description: "A-share pharmaceutical commercial stocks continue to decline, with Shuyu Pingmin dropping over 18%. HRPC, DAJIAWEIKANG, INT'L GROUP, and Hezong Medicine Easy-To-Buy Pharmaceutical all fell more than 5%, while Huaren Health, CQP, and Kaikai Industry also followed suit" datetime: "2025-12-29T05:13:19.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/270952566.md) - [en](https://longbridge.com/en/news/270952566.md) - [zh-HK](https://longbridge.com/zh-HK/news/270952566.md) --- # A-share pharmaceutical commercial stocks continue to decline, with Shuyu Pingmin falling over 18%. HRPC, DAJIAWEIKANG, INT'L GROUP, and Hezong Medicine Easy-To-Buy Pharmaceutical all dropped more than 5%, while Huaren Health, CQP, and Kaikai Industrial also followed suit ### Related Stocks - [000950.CN](https://longbridge.com/en/quote/000950.CN.md) - [301126.CN](https://longbridge.com/en/quote/301126.CN.md) - [600829.CN](https://longbridge.com/en/quote/600829.CN.md) - [300937.CN](https://longbridge.com/en/quote/300937.CN.md) - [000411.CN](https://longbridge.com/en/quote/000411.CN.md) ## Related News & Research - [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md) - [13:21 ETAscent Strategy Group Named One of the Best Healthcare PR Agencies in the World](https://longbridge.com/en/news/286948953.md) - [Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities | DTCFF Stock News](https://longbridge.com/en/news/286870222.md) - [](https://longbridge.com/en/news/286948461.md) - [EXCLUSIVE-FDA drug center head expected to leave after commissioner's exit, sources say](https://longbridge.com/en/news/286589761.md)